Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1996-2-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1883-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8541118-Antigens, CD34,
pubmed-meshheading:8541118-Antineoplastic Agents,
pubmed-meshheading:8541118-Apoptosis,
pubmed-meshheading:8541118-Drug Resistance, Neoplasm,
pubmed-meshheading:8541118-Humans,
pubmed-meshheading:8541118-Leukemia, Myeloid,
pubmed-meshheading:8541118-Middle Aged,
pubmed-meshheading:8541118-Stem Cell Factor
|
pubmed:year |
1995
|
pubmed:articleTitle |
Human stem cell factor protects CD34 positive human myeloid leukaemia cells from chemotherapy-induced apoptosis.
|
pubmed:publicationType |
Letter
|